EGOO IS IMPLEMENTING A

SARS-CoV-2 TEST

 

 

A rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19

 

EGOO'S

SARS-CoV-2

 

 

"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities. An accurate test delivered close to the patient can be transformative - and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities."

Peter Warthoe, CSO, Qlife.

EGOO'S

SARS-CoV-2

 

 

Qlife has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID -19. The test leverages the design principles of our current Egoo Home System techno-

logy, in which multiple regions of the viral genome

are targeted.

 

The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in approximately 20 minutes with less than a minute of hands on time to prepare the sample. 

 

Egoo's SARS-CoV-2 can be utilized in multiple settings where  actionable test results are needed to make informed treatment decisions quickly. The test delivers near-patient results with the same level of performance seen in reference labs. The test is designed for use on Qlife's Egoo Home System.

TEST PROCEDURE

1.

5.

2.

6.

3.

7.

4.

8.

FAQS RELATED TO SARS-CoV-2

 

 

 

  

0

EGOO.HEALTH

Borupvang 3

DK-2750 Ballerup

Denmark

CVR 39982277

info@egoo.health